
Loading, please wait...

Loading, please wait...

Talking with Voices-II was a rater-blinded, parallel-arm, multisite randomized controlled trial in community NHS mental health services at four UK sites. It randomized 309 adults (mean age 41) with serious mental health problems and distressing, persistent auditory hallucinations to Talking with Voices (TwV) plus treatment as usual or treatment as usual alone. TwV is a lived-experience-informed therapy in which the therapist engages in direct dialogue with the voices; participants could receive up to 26 individual 60-minute sessions over 8 months, plus up to four booster sessions. The primary outcome was personal recovery on the Questionnaire about the Process of Recovery (QPR) at 8 months. The TwV group scored on average 6.97 points higher on the QPR than the usual-care group and had significantly better scores on 12 of 15 secondary outcomes, including voice severity, negative self-beliefs and PTSD symptoms. At 14 months, the TwV group still scored 3.5 points higher on the QPR. The authors concluded that TwV significantly improves personal recovery, showing efficacy for individuals with serious mental health problems who experience distressing voices.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Talking with Voices-II was a rater-blinded, parallel-arm, multisite randomized controlled trial in community NHS mental health services at four UK sites. It randomized 309 adults (mean age 41) with serious mental health problems and distressing, persistent auditory hallucinations to Talking with Voices (TwV) plus treatment as usual or treatment as usual alone. TwV is a lived-experience-informed therapy in which the therapist engages in direct dialogue with the voices; participants could receive up to 26 individual 60-minute sessions over 8 months, plus up to four booster sessions. The primary outcome was personal recovery on the Questionnaire about the Process of Recovery (QPR) at 8 months. The TwV group scored on average 6.97 points higher on the QPR than the usual-care group and had significantly better scores on 12 of 15 secondary outcomes, including voice severity, negative self-beliefs and PTSD symptoms. At 14 months, the TwV group still scored 3.5 points higher on the QPR. The authors concluded that TwV significantly improves personal recovery, showing efficacy for individuals with serious mental health problems who experience distressing voices.
Today

A landmark study reveals that congenital DLK1 deficiency in women with a history of central precocious puberty causes visceral adiposity, mitochondrial dysfunction, oxidative stress, and neutrophil activation, highlighting the critical need for lifelong cardiometabolic surveillance.
Today

Estetrol (E4), a native fetal estrogen, offers a unique tissue-selective profile with minimal hepatic impact and lower thrombotic risk. This review highlights its clinical use in oral contraception, menopausal symptom management, and emerging applications across oncology and neurology.
Today

Explore revascularisation strategies in dialysis-dependent chronic limb-threatening ischaemia. This review examines surgical bypass vs endovascular therapy, BEST-CLI trial findings, procedural morbidity, conduit availability, and multidisciplinary decision-making for optimal limb salvage.
Today

A recent cross-sectional analysis reveals that over a quarter of randomized controlled trials for non-specific low back pain face discontinuation or unknown status, while more than 36% of completed trials remain unpublished, exposing notable reporting gaps in spine and musculoskeletal clinical research.
Today

This case report examines the longitudinal CBCT evolution of Stage 2 MRONJ in a 70-year-old woman on denosumab at the site of a pre-existing mandibular dense bone island. It emphasizes the radiographic features, differential diagnosis, and multidisciplinary strategies required for high-risk bone lesions.
Today